LEO Pharma Inc. Debuts LEO(R) Quality Care Program for Plaque Psoriasis Patients - MarketWatch (press release)

LEO Pharma Inc. Debuts LEO(R) Quality aid Program for Plaque disease of the skin Patients MarketWatch (press release) Patients who are already enrolled in the system will continue to get updated materials, information and support from LEO pharmaceutical company Inc. Psoriasis is type A non-contagious, chronic inflammatory cutis disease that affects AN estimated 125 million grouping ... LEO Pharma Inc. Debuts LEO® Quality aid Program for Plaque disease of the skin Patients EON: Enhanced Online News (press release) each 8 news articles » Link To Article